Do ginger-derived nanoparticles represent an attractive treatment strategy for inflammatory bowel diseases?

Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer

(2016) Mingzhen Zhang et al.   BIOMATERIALS

Nanoparticle-based oral delivery systems for colon targeting: principles and design strategies

(2016) Lei Lu et al.   Science Bulletin

Inhibition of MDR1 gene expression and enhancing cellular uptake for effective colon cancer treatment using dual-surface-functionalized nanoparticles

(2015) Bo Xiao et al.   BIOMATERIALS

How will new and future therapies change our treatment of IBD?

(2015) Sebastian Zundler et al.   Expert Review of Clinical Immunology

Ginger and Its Constituents: Role in Prevention and Treatment of Gastrointestinal Cancer

(2015) Sahdeo Prasad et al.   Gastroenterology Research and Practice

Nanotechnology in the treatment of inflammatory bowel diseases

(2014) Angelo Viscido et al.   Journal of Crohns & Colitis

Drug delivery strategies in the therapy of inflammatory bowel disease

(2013) Christian Lautenschläger et al.   ADVANCED DRUG DELIVERY REVIEWS

Grape Exosome-like Nanoparticles Induce Intestinal Stem Cells and Protect Mice From DSS-Induced Colitis

(2013) Songwen Ju et al.   MOLECULAR THERAPY

Targeted Drug Delivery to Intestinal Macrophages by Bioactive Nanovesicles Released from Grapefruit

(2013) Baomei Wang et al.   MOLECULAR THERAPY

Tracking the Down-Regulation of Folate Receptor-α in Cancer Cells through Target Specific Delivery of Quantum Dots Coupled with Antisense Oligonucleotide and Targeted Peptide

(2013) Ming-Zhen Zhang et al.   Small

Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis

(2010) Masayuki Fukata et al.   INFLAMMATORY BOWEL DISEASES